CV-Lynda Krasenbaum



LYNDA JOYCE KRASENBAUM, MSN, ANP-BC

EDUCATION:

UNIVERSITY OF PENNSYLVANIA, Philadelphia, Pennsylvania

Master of Science in Nursing and Adult Primary Care Nurse Practitioner: August 1998

Post-Master's Certificate in Teaching: June 1998

JOHNS HOPKINS UNIVERSITY, Baltimore, Maryland

Completed two Nursing Graduate courses: Spring and Fall 1995

SYRACUSE UNIVERSITY, Syracuse, New York

Bachelor of Science in Nursing with double major in Nursing and Psychology: May 1993

UNIVERSITY OF ALABAMA, Tuscaloosa, Alabama

Completed Freshman Undergraduate coursework: Fall 1988 through Spring 1989

NURSE PRACTITIONER PROGRAM CLINICAL EXPERIENCES:

Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.

General Internal Medicine and Hypertension Clinics

Veteran's Affairs Medical Center, Philadelphia, Pennsylvania.

Emergency Room and General Internal Medicine Clinic

EMPLOYMENT/APPOINTMENTS:

Headache: The Journal of Head and Face Pain (01/17-pres.)

Associate Provider Editor

Writes reviews of current articles in journal, pertinent to physicians, nurse practitioners,

physician assistants, and other medical professionals.

New York Headache Center, New York, New York.

Associate Director/Nurse Practitioner (05/06-pres.)

Specializes in the diagnosis, treatment, and management of various headache, facial pain, and

sleep disorder conditions in adults. Assists with pharmaceutical drug trials as a co-investigator,

specific to the headache/pain population. Teaches and educates the general population and

medical professionals.

Columbia University Headache Center, New York, New York.

Nurse Practitioner—Section of Neurology (04/03-05/06)

Specialized in the diagnosis, treatment, and management of various headache, facial pain, and

sleep disorder conditions in adults. Taught and educated the general population and medical

professionals.

Columbia University, New York, New York.

Assistant Professor of Clinical Nursing (04/03-05/10)

Informally taught nursing students headache diagnosis, treatment, and management practices.

Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire.

Nurse Practitioner–Section of Neurology (06/00-04/03)

Specialized in the treatment and management of various headache and facial pain conditions in

all age groups. Assisted with pharmaceutical drug trials as a co-investigator, specific to the

headache/pain population. Taught and educated the general population and medical

professionals.

Dartmouth Medical School, Lebanon, New Hampshire.

Instructor of Medicine (06/00-04/03)

Taught nursing and medical students headache diagnosis, treatment and management practices

both formally and informally.

Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.

Advanced Practice Nurse--General and Intermediate Care Neuro Units (10/98-06/00)

Promoted best practice outcomes by focusing on quality of care, efficiency, and cost-effective

care practices. Provided patient and nursing staff education with respect to

neurological/surgical conditions, procedures, and treatments. Actively participated in

multidisciplinary patient rounds. Involved in management committees, i.e. quality

improvement, practice, and pathway development. Regularly taught neuroscience to critical

care nurses in HUP’s Critical Care Course.

Johns Hopkins Hospital, Baltimore Maryland.

Clinical Nurse--Neurosciences, Ortho-Spine, and Epilepsy Unit (04/95-07/97)

Provided nursing care for neurosurgical patients after procedures including Laminectomies and

Fusions, Brachial Plexus Injuries, Peripheral Nerve Disorders, Craniotomies, and

Pallidotomies. Cared for those suffering from neurological disorders, such as Strokes, Multiple

Sclerosis, Seizure Disorders, and AIDS Dementia. Performed nursing care for extensive back

surgery patients and chronic pain patients.

Clinical Nurse--Affective and Eating Disorder Unit (12/93-04/95)

Provided nursing care for psychiatric patients with mania, depression, anorexia, bulimia.

Performed such skills as therapeutic communication, goal directing, limit setting, eating

disorder management, assisted with shock therapy.

Clinical Nurse--Cardiac Surgical Intensive Care Unit (07/93-12/93)

Provided nursing care for patients following bypass surgery, valve replacement, and heart

transplants.

RELEVANT EXPERIENCE:

• Involved in numerous speaking engagements focusing on headache diagnosis, treatment and management practices.

• Speaks to physicians, nurse practitioners, physician assistants, pharmacists, and other healthcare providers at both CME conferences and for pharmaceutical companies.

• CEU/CME granted engagements:

▪ AHS Scottsdale Headache Symposium (The Bridge: Diagnosing Headache in Adults and Adolescent Patients) Scottsdale, AZ (2017)

▪ AHS Scottsdale Headache Symposium (Injection Training Demonstrator) Scottsdale, AZ (2017)

▪ National Nurse Practitioner Symposium (The Bridge: A Comprehensive Headache Education Program—Designed for Nurse Practitioner & Physician Assistants in Primary Care) Keystone, CO (2017)

▪ The Bridge: A Comprehensive Headache Education Program—Designed for Nurse Practitioners & Physician Assistants in Primary Care, Baltimore, MD (2016)

▪ AHS 58th Annual Scientific Meeting (The Bridge: Diagnosing Headache in Adults and Adolescent Patients) San Diego, CA (2016)

▪ AHS 2015 Scottsdale Headache Symposium (Mid-Level Roles in Headache Management: Concrete Case Examples) Scottsdale, AZ (2015)

▪ AANP 2014 National Conference (Chronic Migraine Foundations: Diagnosis, Treatment and Patient Expectations program—Allergan sponsored) Nashville, TN (2014)

▪ Second International Headache Summit, Tel Aviv, Israel (2011)

▪ First International Headache Summit, Tel Aviv, Israel (2008)

▪ Annual Symposium on Treatment of Headaches and Facial Pain, New York, NY (2007, 2008, 2009, 2010);

▪ NPACE Regional Conferences (Nurse Practitioner Associates for Continuing Education) in the following cities (some numerous times): Atlanta, GA, Boston, MA, Brewster, MA, Cambridge, MA, Chicago, IL, Mashantucket, CT, Nassau, Bahamas, New Orleans, LA, North Falmouth, MA, Orlando, FL, St. Louis, MO —(2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011);

▪ Headache Mini-Fellowship by Columbia University College of Physicians and Surgeons—Nationwide (2003-2004-2005);

▪ HCNE (Headache Consortium of New England) Annual Headache Conference in Stowe, VT (2003);

▪ DHMC (Dartmouth Hitchcock Medical Center) Headache Symposium, Lebanon, NH (2003);

▪ MUD Season Nursing Symposium (North Country Health Consortium) in North Conway, NH;

▪ Quarterly NP meeting for the Greater Keene/Peterborough, NH area;

▪ Dartmouth Hitchcock Medical Center Certified Neuroscience Registered Nurse (CNRN) preparatory course, Lebanon, NH;

▪ Critical Care nursing course (Neuroscience focus) at the Hospital of the University of Pennsylvania, Philadelphia, PA.

• Community speaking engagements on headache and migraines:

▪ El Paso Area NP Group (Merck sponsored)—Educational Program, Sunland Park, NM

▪ LX NewYork/NBC local station—Segment on migraines and alternative treatments, New York, NY

▪ Guardian Life Insurance—Educational Program, New York, NY

▪ TIAA-CREF Insurance—Educational Program, New York, NY

▪ St. Joseph’s Hospital—Educational Program in Nashua, NH

• Current appointments:

▪ Allergan—Advisory Board/Promotional Speaker

▪ Amgen/Novartis—Advisory Board/Promotional Speaker

▪ Avanir—Advisory Board

▪ Supernus Pharmaceuticals—Consultant

▪ Teva Pharmaceutical Industries—Advisory Board/Promotional Speaker

• Former appointments:

▪ Abbott Pharmaceuticals Advisory Board

▪ AstraZeneca Promotional Speaker

▪ Glaxo-SmithKline Promotional Speaker

▪ Janssen Biotech Inc. Promotional Speaker

▪ MAP Pharmaceuticals Advisory Board

▪ Merck & Company Promotional Speaker

▪ Pernix Therapeutics—Promotional Speaker

▪ Zogenix Advisory Board/Promotional Speaker

LICENSURES, CERTIFICATIONS, AND MEMBERSHIPS:

• Currently nationally board certified as an Adult Nurse Practitioner by American Nurses Credentialing Center (ANCC).

• Currently state certified as an Adult Nurse Practitioner in New York and formerly in New Hampshire, Massachusetts, and Pennsylvania.

• Currently licensed as an RN in New York and formerly in New Hampshire, Massachusetts, Pennsylvania and Maryland.

• Member of Sigma Theta Tau International Honor Society of Nursing (STTI).

• Member of American Association of Nurse Practitioners (AANP).

• Member of the Nurse Practitioner Association of New York State (NPA).

• Member of International Headache Society (IHS).

• Member of American Headache Society (AHS).

• Member of American Association of Neuroscience Nurses (AANN).

• Member of American Nurses Association (ANA).

• Current DEA# for prescription writing.

PUBLICATIONS:

Krasenbaum, L. J. (2017). A Review of HIV and Headache: A Cross-Sectional Study.

Headache: The Journal of Head and Face Pain, 57: 1545-1550.

Krasenbaum, L. J. (2017). A Review of Migraine Prophylaxis and Acute Treatment Patterns

Among Commercially Insured Patients in the United States. Headache: The Journal of Head

And Face Pain, 57: 1399-1408.

Krasenbaum, L. J. (2017). A Review of Complementary and Alternative Medicine Use Among

US Adults With Headache or Migraine: Results from the 2012 National Health Interview

Survey. Headache: The Journal of Head and Face Pain, 57: 1228-1242.

Krasenbaum, L. J. (2017). A Review of Allodynia is Associated with Initial and Sustained

Response to Acute Migraine Treatment: Results from the American Migraine Prevalence and

Prevention (AMPP) Study. Headache: The Journal of Head and Face Pain, 57: 1026-1040.

Krasenbaum, L. J. (2017). A Review of Vomiting and Migraine-Related Clinical Parameters in

Pediatric Migraine. Headache: The Journal of Head and Face Pain, 57: 979–980.

Krasenbaum, L. J. (2017). A Review of Radiofrequency for Arteriovenous Malformations and

the Impact on Headache. Headache: The Journal of Head and Face Pain, 57: 812–813.

Krasenbaum, L. J. (2017). A Review of CGRP and Its Receptors. Headache: The Journal of

Head and Face Pain, 57: 670–671.

Krasenbaum, L. J. (2017). A Review of “Untangling the Association Between Migraine, Pain,

and Anxiety: Examining Migraine and Generalized Anxiety Disorders in a Canadian Population

Based Study”. Headache: The Journal of Head and Face Pain, 57: 500–501.

Krasenbaum, L. J. (2017). A Review of “Hormonal Contraceptives and Migraine With Aura –

Is There Still a Risk?”. Headache: The Journal of Head and Face Pain, 57: 313.

Krasenbaum, L. J. (2017). A Review of “Peripheral Nerve Blocks for the Treatment of

Headache in Older Adults: A Retrospective Study”. Headache: The Journal of Head and Face

Pain, 57: 128.

CLINICAL INVESTIGATIONS:

Non-Invasive Neurostimulation of the Vagus Nerve with the GammaCore™ device for the

Relief of Symptoms Associated with Migraine. In Association with Alexander Mauskop and

ElectroCore., 2012 .

Effect of Septal Closure of Atrial PFO on Events of Migraine with Premere: ESCAPE

Migraine Trial. In Association with Alexander Mauskop and Velocimed, Inc., d/b/a St. Jude

Medical, Inc., May 2006 to January 2008.

A Multicenter Study Evaluating the Efficacy and Safety of Botox( (Botulinum Toxin Type A)

Purified Neurotoxin Complex as Headache Prophylaxis in Migraine Patients with 15 or More

Headache Days per 4-Week Period in a 24-Week, Double-Blind, Randomized, Placebo-

Controlled, Parallel-Group Phase Followed by a 32-Week Open-label Extension Phase. In

Association with Alexander Mauskop and Allergan, May 2006 to 2008.

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study of

Botox( (Botulinum Toxin Type A) Purified Neurotoxin Complex for the Prophylactic

Treatment of Headaches in the Chronic Headache Population. In Association with Thomas N.

Ward and Allergan, June 2001 to May 2003.

A Double-Blind, Placebo-Controlled, Three-Way Cross-Over Clinical Study to Assess the

Safety and Efficacy of Two Dose Regimens of Frovatriptan, Compared with Placebo, in

Preventing Menstrually-Associated Migraine (MAM) Headache. In Association with Thomas

N. Ward and Vernalis Limited, June 2001 to May 2003.

An Open-Label Safety and Immunogenicity Study of Myobloc( (Neurobloc(; Botulinum

Toxin Type B) Injectable Solution in Patients with Cervical Dystonia. In Association with

Thomas N. Ward and Elan Pharmaceuticals, Inc., April 2001 to May 2003.

A Multicenter, Randomized, Placebo-controlled, Double-blind, Parallel-group trial to Evaluate

the Efficacy and Tolerability of the Zolmitriptan (ZOMIG() 5-mg Orally Disintegrating Tablet

in the Acute Treatment of Adult Subjects with Migraine Headache. In Association with

Thomas N. Ward and AstraZeneca LP, December 2000 to May 2003.

A Multicenter, Randomized, Placebo-controlled, Double-blind, Parallel-group Trial to

Evaluate the Efficacy and Tolerability of the Zolmitriptan (ZOMIG() 2.5-mg Orally

Disintegrating Tablet When Taken As Soon As Possible after the Onset in the Acute Treatment

of Migraine Headache. In Association with Thomas N. Ward and AstraZeneca LP, December

2000 to October 2001.

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Single-Attack Evaluation of

Sumatriptan 50mg and 100mg versus placebo during a Migraine Headache at the first sign of

pain. In Association with Thomas N. Ward and Glaxo Wellcome, Inc., August 2000 to

January 2001.

An Open-Label Evaluation of the Long-Term Safety of Oral Naratriptan 1 Mg Twice Daily as

Short-Term Prophylactic Treatment for Menstrually-Associated Migraine. In Association with

Morris Levin and Glaxo Wellcome, Inc., February 2000 to July 2001.

An Open-label, Long-term Observational Study of the Safety and Tolerability

of Sumatriptan Nasal Spray in the Treatment of Migraine in Adolescents. In Association with

Thomas N. Ward and Glaxo Wellcome, Inc., May 2000 to October 2001.

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download